586 related articles for article (PubMed ID: 23973347)
21. [Maternal and perinatal infections to Streptococcus agalactiae].
Six A; Joubrel C; Tazi A; Poyart C
Presse Med; 2014 Jun; 43(6 Pt 1):706-14. PubMed ID: 24855049
[TBL] [Abstract][Full Text] [Related]
22. The prevention of early-onset neonatal group B streptococcus infection: technical report from the New Zealand GBS Consensus Working Party.
Campbell N; Eddy A; Darlow B; Stone P; Grimwood K;
N Z Med J; 2004 Aug; 117(1200):U1023. PubMed ID: 15475993
[TBL] [Abstract][Full Text] [Related]
23. Group B Streptococcus: Trials and Tribulations.
Davies HG; Carreras-Abad C; Le Doare K; Heath PT
Pediatr Infect Dis J; 2019 Jun; 38(6S Suppl 1):S72-S76. PubMed ID: 31205250
[TBL] [Abstract][Full Text] [Related]
24. A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women.
Leroux-Roels G; Maes C; Willekens J; De Boever F; de Rooij R; Martell L; Bedell L; Wittke F; Slobod K; Dull P
Vaccine; 2016 Apr; 34(15):1786-91. PubMed ID: 26928074
[TBL] [Abstract][Full Text] [Related]
25. Maternal group B streptococcal immunization: capsular polysaccharide (CPS)-based vaccines and their implications on prevention.
Palmeiro JK; De Carvalho NS; Botelho AC; Fracalanzza SE; Madeira HM; Dalla-Costa LM
Vaccine; 2011 May; 29(21):3729-30. PubMed ID: 21414381
[TBL] [Abstract][Full Text] [Related]
26. Group B Streptococcus Colonization in Late Pregnancy and Invasive Infection in Neonates in China: A Population-Based 3-Year Study.
Zhu Y; Huang J; Lin XZ; Chen C
Neonatology; 2019; 115(4):301-309. PubMed ID: 30808831
[TBL] [Abstract][Full Text] [Related]
27. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
[TBL] [Abstract][Full Text] [Related]
28. Status of vaccine research and development of vaccines for GBS.
Heath PT
Vaccine; 2016 Jun; 34(26):2876-2879. PubMed ID: 26988258
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance.
Nanduri SA; Petit S; Smelser C; Apostol M; Alden NB; Harrison LH; Lynfield R; Vagnone PS; Burzlaff K; Spina NL; Dufort EM; Schaffner W; Thomas AR; Farley MM; Jain JH; Pondo T; McGee L; Beall BW; Schrag SJ
JAMA Pediatr; 2019 Mar; 173(3):224-233. PubMed ID: 30640366
[TBL] [Abstract][Full Text] [Related]
30. Group B streptococcal disease in infants: progress in prevention and continued challenges.
Verani JR; Schrag SJ
Clin Perinatol; 2010 Jun; 37(2):375-92. PubMed ID: 20569813
[TBL] [Abstract][Full Text] [Related]
31. Group B streptococcal infection in Taiwan: maternal colonization and neonatal infection.
Yu HW; Lin HC; Yang PH; Hsu CH; Hsieh WS; Tsao LY; Chen CH; Lin HC; Tseng YC
Pediatr Neonatol; 2011 Aug; 52(4):190-5. PubMed ID: 21835363
[TBL] [Abstract][Full Text] [Related]
32. Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination.
Berardi A; Cattelani C; Creti R; Berner R; Pietrangiolillo Z; Margarit I; Maione D; Ferrari F
Expert Rev Anti Infect Ther; 2015; 13(11):1387-99. PubMed ID: 26295167
[TBL] [Abstract][Full Text] [Related]
33. Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study.
Rivera L; Sáez-Llorens X; Feris-Iglesias J; Ip M; Saha S; Adrian PV; Madhi SA; Boudville IC; Cunnington MC; Casellas JM; Slobod KS
BMC Pediatr; 2015 Oct; 15():143. PubMed ID: 26427955
[TBL] [Abstract][Full Text] [Related]
34. Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches.
Absalon J; Simon R; Radley D; Giardina PC; Koury K; Jansen KU; Anderson AS
Hum Vaccin Immunother; 2022 Dec; 18(1):2037350. PubMed ID: 35240933
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis.
Renner RM; Renner A; Schmid S; Hoesli I; Nars P; Holzgreve W; Surbek DV
J Perinat Med; 2006; 34(1):32-8. PubMed ID: 16489884
[TBL] [Abstract][Full Text] [Related]
36. WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016.
Kobayashi M; Schrag SJ; Alderson MR; Madhi SA; Baker CJ; Sobanjo-Ter Meulen A; Kaslow DC; Smith PG; Moorthy VS; Vekemans J
Vaccine; 2019 Nov; 37(50):7307-7314. PubMed ID: 28017431
[TBL] [Abstract][Full Text] [Related]
37. Early-onset neonatal group B streptococcal infection: implications for practice.
Parks DK; Yetman RJ; Moyer V; Kennedy K
J Pediatr Health Care; 2000; 14(6):264-9. PubMed ID: 11112918
[TBL] [Abstract][Full Text] [Related]
38. Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center study.
Lohrmann F; Hufnagel M; Kunze M; Afshar B; Creti R; Detcheva A; Kozakova J; Rodriguez-Granger J; Sørensen UBS; Margarit I; Maione D; Rinaudo D; Orefici G; Telford J; de la Rosa Fraile M; Kilian M; Efstratiou A; Berner R; Melin P;
Infection; 2023 Aug; 51(4):981-991. PubMed ID: 36547864
[TBL] [Abstract][Full Text] [Related]
39. Perinatal infection with Group B streptococci.
Pettersson K
Semin Fetal Neonatal Med; 2007 Jun; 12(3):193-7. PubMed ID: 17347062
[TBL] [Abstract][Full Text] [Related]
40. Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation.
Davies HD; Raj S; Adair C; Robinson J; McGeer A;
Pediatr Infect Dis J; 2001 Sep; 20(9):879-84. PubMed ID: 11734768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
